Download PDF
Diabetologie und Stoffwechsel 2013; 8(6): 428-442
DOI: 10.1055/s-0033-1356293
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Das diabetische Fußsyndrom – Pathophysiologie, Diagnostik und Therapie

Diabetic Foot Syndrome – Pathophysiology, Diagnosis and Therapy
R. Brandl
1   Praxis für Gefäßchirurgie und Venenmedizin am Marienplatz, München
,
H. Stiegler
1   Praxis für Gefäßchirurgie und Venenmedizin am Marienplatz, München
› Author Affiliations
Further Information

Publication History

Publication Date:
20 December 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Diabetes - neuropathisches Ulkus - neuroischämische Fußläsion - Prophylaxe

Key words

diabetic foot ulcer - neuropathy - ischemic foot ulcer - prophylaxis
 

  • Literatur

  • 1 Adam DJ, Beard JD, Cleveland T et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934
    CrossrefPubMedGoogle Scholar
  • 2 American College of Sports Medicine (ACSM). ACSM's guidelines for Exercise Testing and prescription. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001
    Google Scholar
  • 3 American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 3333-3341
    CrossrefGoogle Scholar
  • 4 Apelquist J, Larsson J, Agadon CD. Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993; 233: 485-491
    CrossrefGoogle Scholar
  • 5 Arbeitsgemeinschaft Diabetischer Fuß der Deutschen Diabetesgesellschaft. http://www.ag-fuss-ddg.de
    Google Scholar
  • 6 Armstrong DG, Lavery LA, Karkless B. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21: 855-859
    CrossrefGoogle Scholar
  • 7 Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366: 1704-1710
    CrossrefGoogle Scholar
  • 8 Boulton AJ. Clinical presentation and management of diabetic neuropathy and foot ulceration. Diabet Med 1991; 8: S52-S57
    CrossrefGoogle Scholar
  • 9 Boulton AJM, Vileikyte L, Ragnarson-Tennvall G et al. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724
    CrossrefGoogle Scholar
  • 10 Bradbury AW, Adam DJ, Bell J et al. Bypass versus Angioplasty in severe ischaemia of the leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010; 51: 18S-31S
    CrossrefPubMedGoogle Scholar
  • 11 Bradbury AW, Adam DJ, Bell J et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass-surgery-first or a balloon-angioplasty-first revascularization strategy. J Vasc Surg 2010; 51: 5S-17S
    Google Scholar
  • 12 Brandl R, Stiegler H. Therapieresistente Wunden der unteren Extremität. Dtsch Med Wochenschr 2007; 132: 1-14
    Article in Thieme ConnectGoogle Scholar
  • 13 Capobianco CM, Stapleton JJ. Diabetic foot infections: a team-oriented review of medical and surgical management. Diabetic Foot & Ankle 2010; 1 DOI: 10.3402/dfa.v1i0.5438. Epub 2010 Sep 13
    Google Scholar
  • 14 Caspary LA, Creutzig A, Alexander K. Orthostatic vasoconstrictor response in patients with occlusive arterial disease assessed by laser Doppler flux and transcutaneous oximetry. Angiology 1996; 47: 165-173
    CrossrefGoogle Scholar
  • 15 Cichosz SL, Fleischer J, Hoeyem P et al. Objective measurements of activity patterns in people with newly diagnosed Type 2 diabetes demonstrate a sedentary lifestyle. Diabet Med 2013; 30: 1063-1066
    CrossrefGoogle Scholar
  • 16 Clare MP, Fitzgibbons TC, McMullen ST et al. Experience with the vacuum assisted closure negative pressure technique in the treatment of non-healing diabetic and dysvascular wounds. Foot ankle Int 2002; 23: 896-901
    Google Scholar
  • 17 Cooper AR, Sebire S, Montgomery AA et al. Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 2012; 55: 589-599
    CrossrefGoogle Scholar
  • 18 DCCT Research Group. The effect of intensive treatment of Diabetes on the development and progression of long-term complications in Insulin-dependent Diabetes mellitus. N Engl J Med 1993; 329: 977-86
    CrossrefGoogle Scholar
  • 19 Eckardt A. Operative Verfahren. In: Eckardt A, Lobmann R, (Hrsg) Der diabetische Fuß. Berlin Heidelberg New York: Springer; 2005: 126-147
    Google Scholar
  • 20 Faglia E, Mantero M, Caminiti M et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225-232
    CrossrefGoogle Scholar
  • 21 Faglia E, Clerici G, Clerissi J et al. Angioplasty for diabetic patients with failing bypass graft or residual critical ischemia after bypass graft. Eur J Vasc Endovasc Surg 2008; 36: 331-338
    CrossrefGoogle Scholar
  • 22 Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg 2011; 53: 220-226
    CrossrefGoogle Scholar
  • 23 Fisher MA, Langbein WE, Collins EG et al. Physiological improvement with moderate exercise in type II diabetic neuropathy. Electromyogr Clin Neurophysiol 2007; 47 (01) 23-28
    Google Scholar
  • 24 Frykberg RG. The high risk foot in diabetes mellitus. Edinburgh: Livingstone; 1991: 1-569
    Google Scholar
  • 25 Gaede P, Lund-Andersen H, Parving HH et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591
    CrossrefGoogle Scholar
  • 26 Haider SN, Kavanagh EG, Forlee M et al. Two-year outcome with preferential use of infrainguinal angioplasty for critical limb ischemia. J Vasc Surg 2006; 43: 504-512
    CrossrefGoogle Scholar
  • 27 Haslbeck M, Luft D, Neundörfer B et al. Diabetische Neuropathie. DDG Praxis-Leitlinie. Aktualisierung 05/2007. Diabetologie 2008; 3 (Suppl. 02) 134-140
    Article in Thieme ConnectGoogle Scholar
  • 28 Haslbeck M, Luft D, Neundörfer B et al. Diagnostik, Therapie und Verlaufskontrolle der Neuropathie bei Diabetes mellitus Typ 1 und Typ 2. Evidenzbasierte Leitlinie DDG. Dt. Diabetes-Ges 2004
    Google Scholar
  • 29 Hauner H. Epidemiologie und Kostenaspekte des Diabetes in Deutschland. Dtsch Med Wochenschr 2005; 130 (Suppl. 02) S64-S65
    Article in Thieme ConnectGoogle Scholar
  • 30 Heller G, Günster C, Schellschmidt H. Wie häufig sind Diabetes-bedingte Amputationen unterer Extremitäten in Deutschland? Eine Analyse auf Basis von Routinedaten. . Dtsch Med Wochenschr 2004; 129: 429-433
    Article in Thieme ConnectGoogle Scholar
  • 31 Hochlehnert D, Engels G, Altenhofen L. Integrierte Versorgung, Ergebnisse des Netzwerk Diabetischer Fuß Köln und Umgebung. Dt Arztebl 2006; 103: A1680-A1683
    Google Scholar
  • 32 Holstein P, Ellitsgaard N, Olsen BB et al. Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000; 43: 844-847
    CrossrefGoogle Scholar
  • 33 Larsen K, Holstein P, Deckert T. Limb salvage in diabetics with foot, ulcers. Prosthet Orthot Int 1989; 13: 100-103
    Google Scholar
  • 34 International Working Group on the Diabetic Foot. International consensus on the diabetic foot & practical guidelines on the diabetic foot. 2007 www.idf.org/bookshop
    Google Scholar
  • 35 Jung V. Fuß-Erhalt bei diabetischer Gangrän. Zentralbl Chir 1996; 121: 387-393
    Google Scholar
  • 36 Kluding PM, Pasnoor M, Singh R et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabet Complications 2012; 26: 424-429
    CrossrefGoogle Scholar
  • 37 Koller A, Metzger C, Möller M et al. Schuhversorgung und Risikoklassen beim diabetischen Fußsyndrom. In: OST Sonderheft Diabetes Orthopädie Schuhtechnik 2005; 45-47
    Google Scholar
  • 38 Larsen K, Holstein P, Deckert T. Limb salvage in diabetics with foot, ulcers. Prosthet Orthot Int 1989; 13: 100-103
    Google Scholar
  • 39 Levin MD, O’Neal LW. The diabetic foot. 4th edn. St. Louis: Mosby; 1988
    Google Scholar
  • 40 Lipsky BA, Berendt AR, Deery HG et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39: 885-910
    CrossrefGoogle Scholar
  • 41 Malmstedt J, Leander K, Wahlberg E et al. Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes. Diabetes Care 2008; 31: 887-892
    CrossrefGoogle Scholar
  • 42 Martin CL, Albers J, Herman WH et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006; 29: 340-344
    CrossrefGoogle Scholar
  • 43 McNeely MJ, Boyko EJ, Ahroni JH et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?. Diabetes Care 1995; 18: 216-219
    CrossrefPubMedGoogle Scholar
  • 44 Morbach S, Müller E, Reike H et al. Evidenzbasierte Leitlinie der Deutschen Diabetesgesellschaft. Diagnostik, Therapie, Verlaufskontrolle und Prävention des diabetischen Fußsyndroms. Diabetologie 2009; 4: 301-325 www.deutsche-diabetes-gesellschaft.de
    Article in Thieme ConnectGoogle Scholar
  • 45 Moss SE, Klein R, Klein BEK. Long-term incidence of lower-extremity amputations in a diabetic population. Arch Fam Med 1996; 5: 391-398
    CrossrefGoogle Scholar
  • 46 Murdoch DP, Armstrong DG, Dacus JB et al. The natural history of great toe amputation. J Foot Ankle Surg 1997; 36: 204-208
    Google Scholar
  • 47 Nationale VersorgungsLeitlinie Typ-2-Diabetes Präventions- und Behandlungsstrategien für Fußkomplikationen. Version 2.8. 2010 http://www.diabetes.versorgungsleitlinien.de (z. Zeitpunkt der Manuskripterstellung in Überprüfung)
    Google Scholar
  • 48 Nationale Versorgungs Leitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. Version 1.2. 2011 http://www.diabetes.versorgungsleitlinien.de http://www.awmf-leitlinien.de
    Google Scholar
  • 49 Nationale Versorgungs Leitlinie Chronische KHK – Langfassung. Version 1, 2013. http://www.awmf.org/uploads/tx_szleitlinien/nvl004l_S3_Chronische_Koronare_Herzkrankheit_2013-07.pdf
    Google Scholar
  • 50 Neundörfer B, Reichel G. Diabetische Neuropathie – Pathogenese und Therapie der peripheren diabetischen Polyneuropathien. Dt. Ärztebl 1996; 93: A963-A968
    Google Scholar
  • 51 Deutsche Gesellschaft für Wundheilung und Wundbehandlung e.V. Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronische venöse Insuffizienz. Stand: 12.06.2012 Version 1. AWMF-Register Nr. 091/001. http://www.awmf-online.de
    Google Scholar
  • 52 Norgren L, Hiatt WR, Dormandy A et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33: S1-S75
    CrossrefPubMedGoogle Scholar
  • 53 Ogrin R, Houghton PE, Thompson GW. Effective management of patients with diabetes foot ulcers: outcomes of an Interprofessional Diabetes Foot Ulcer Team. Int Wound 2013; DOI: 10.1111/iwj.12119. [Epub ahead of print]
    Google Scholar
  • 54 Patienten Leitlinie zur Nationalen Versorgungs Leitlinie Typ-2-Diabetes. Prävention und Behandlungsstrategien für Fußkomplikationen. Version 01.01 vom April 2008. http://www.diabetes.versorgungsleitlinien.de
    Google Scholar
  • 55 Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442-1447
    CrossrefGoogle Scholar
  • 56 Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischemia, infection and serious comorbidities in patients with diabetic foot disease in Europe; Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25
    CrossrefGoogle Scholar
  • 57 Rademacher T. Septische Knochenchirurgie am neuropathischen diabetischen Vorfuß – Nutzen und Risiken. Akt Chir 1999; 32: 101-103
    Google Scholar
  • 58 Reichel G. Diabetes und Nerv. In: Bibergeil H, Hrsg Diabetes mellitus. Jena: Gustav Fischer; 1989: 513-536
    CrossrefGoogle Scholar
  • 59 Reike H. Wundheilung und lokale Wundbehandlung bei diabetischem Fußsyndrom. Internist 1999; 40: 1009-1117
    CrossrefGoogle Scholar
  • 60 Rosenberger HE, Goff DC, Isom S et al. Relationship of weekly activity minutes to metabolic syndrome in prediabetes: the healthy living partnerships to prevent diabetes. J Phys Act Health 2013; 10: 690-698
    Google Scholar
  • 61 Rümenapf G, Lang W, Morbach S. Minoramputationen bei Diabetischem Fußsyndrom. Orthopäde 2009; 38: 1160-1170
    CrossrefGoogle Scholar
  • 62 Rümenapf G, Dentz J, Pascucci S et al. Das diabetische Fußsyndrom. Teil 1: Definition, Pathophysiologie, Diagnostik und Klassifikation. Gefässchirurgie 2010; 15: 209-220
    CrossrefGoogle Scholar
  • 63 Rümenapf G, Deutz J, Amendt K et al. Das diabetische Fußsyndrom. Teil 2: Therapie, Prävention, Versorgungsstrukturen. Gefässchirurgie 2010; 15: 345-360
    CrossrefGoogle Scholar
  • 64 Sanders LJ, Frykberg RG. The Charcot foot (Pied de Charcot). In: Bowker JH, Pfeifer MA, Eds Levin and O'Neal's The Diabetic Foot. 7th ed. Philadelphia: Mosby Elsevier; 2007: 257-283
    Google Scholar
  • 65 Sanders LJ. Diabetes mellitus. Prevention of amputation. J Am Podiatr Med Assoc 1994; 84: 322-328
    Google Scholar
  • 66 Scherbaum WA, Haak T. (Hrsg) Körperliche Aktivität und Diabetes mellitus. Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft. AWMF Reg.-Nr. 057-022. www.deutsche-diabetes-gesellschaft.de
    Google Scholar
  • 67 Schofield CJ, Libby G, Brennan GM et al. Mortality and hospitalization in patients after amputation. Diabetes Care 2006; 29: 2252-2256
    CrossrefGoogle Scholar
  • 68 Seewald M. Mikrobiologische Aspekte in der Diagnostik und Therapie des diabetischen Fußes. Diabetes Stoffw 1999; 8 (Suppl. 05) 16-20
    Google Scholar
  • 69 Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228
    CrossrefPubMedGoogle Scholar
  • 70 Smith AG, Russell J, Feldman EL et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29: 1294-1299
    CrossrefPubMedGoogle Scholar
  • 71 Stevens DL, Bisno AL, Chambers HF et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41: 1373-1406
    CrossrefGoogle Scholar
  • 72 Stiegler H. Langzeitdiabetiker mit überwärmtem und geschwollenem Fuß. MMW-Fortschr 2010; 25: 1-3
    Google Scholar
  • 73 Stiegler H. Das diabetische Fußsyndrom. Herz 2004; 29: 104-115
    CrossrefGoogle Scholar
  • 74 Stiegler H, Diehm C, Grom E et al. Placebo controlled, double-blind study of the effectiveness of i. v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease. Vasa Suppl 1992; 35: 164-166
    Google Scholar
  • 75 Sumpio BE, Armstrong DG, Lavery LA et al. J Am Podiatr Med Assoc. 2010; 100: 309-311
    Google Scholar
  • 76 Tesfaye S, Chaturvedi N, Eaton SE et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341-350
    CrossrefPubMedGoogle Scholar
  • 77 Tessier D, Menard J, Fulop T et al. Effects of aerobic physical exercise in the elderly with type 2 diabetes mellitus. Arch Gerontol Geriatr 2000; 31 (02) 121-132 http://www.ncbi.nlm.nih.gov/pubmed/11090907
    CrossrefGoogle Scholar
  • 78 Teuscher A, Hermann JB, Studer PP. Vaskuläre Erkrankungen bei 534 Schweizer Diabetikern im Rahmen einer multinationalen Studie. Klin Wochenschr 1983; 61: 139-149
    CrossrefGoogle Scholar
  • 79 Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 3 :CD002968. http://www.ncbi.nlm.nih.gov/pubmed/16855995
    Google Scholar
  • 80 Tooke JE, Brash PD. Microvascular aspects of diabetic foot disease. Diabet Med 1996; 13: 26-29
    Google Scholar
  • 81 Uccioli L, Faglia E, Monticoni G. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995; 18: 1376-1378
    CrossrefGoogle Scholar
  • 82 Wagner AH, Reike H, Angelkort B. Erfahrungen im Umgang mit hochresistenten Keimen bei Patienten mit diabetischem Fuß-Syndrom unter besonderer Berücksichtigung von MRSA-Infektionen. Dtsch Med Wochenschr 2001; 126: 1353-1356
    Article in Thieme ConnectGoogle Scholar
  • 83 Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2: 64
    CrossrefGoogle Scholar
  • 84 Wahlberg E, Jörneskog G, Olofsson P et al. The influence of reactive hyperemia and leg dependency on skin microcirculation in patients with peripheral arterial occlusive disease (PAOD), with and without diabetes. VASA 1990; 19: 301-306
    Google Scholar
  • 85 Wölfle KD, Loeprecht H, Bruijnen H. 5 Jahre Erfahrung mit kruromalleolären Bypassoperationen. Komplikationen und Ergebnisse. Angio Arch 1991; 21: 109-112
    Google Scholar
  • 86 Wölfle KD, Bruijnen H, Loeprecht H et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg 2003; 25: 229-234
    CrossrefGoogle Scholar
  • 87 Zwierska I, Walker RD, Choksy SA et al. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. Vasc Surg 2005; 42: 1122-1130
    CrossrefGoogle Scholar